Neoadjuvant Keytruda for patients with deficient DNA mismatch repair colon cancer resulted in a pathological complete ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...

A new advisory from the American Heart Association strongly endorses endovascular treatment for patients with large core ...

Jan. 15, 2025 — Patients with a common aggressive type of bladder cancer could get correct treatment significantly ... Behind the Shifting Trends of Ischemic Heart Disease and Stroke Nov ...

The researchers hope it will pave the way for new treatment ... Vitamin D Supplements ... Nov. 20, 2024 — Incidence of stroke and ischemic heart disease are declining around the world, except ...

“Patients sometimes tell me that they ‘hear bad things’ about [ED treatments],” Dr. Gross told The Post. “These medications are among the most broadly prescribed drugs of the last ...

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

by Mr Timothy Biggs, Dr Sarah Pickering and Mr Mandar Jog ...